WALTHAM, Ma., Sept. 09, 2024 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare
professionals (HCPs) and prospective patients, today announces the leading AI-driven marketing technology for healthcare consumers, Micro-Neighborhood Targeting (MNT), offered on the Company’s
Dynamic Audience Activation Platform (DAAP), which now further unifies outreach to patient and provider audiences via the incorporation of brand eligibility signals to consumer marketing. This
enhancement to DAAP enables pharmaceutical brands to deliver synchronized, AI-guided Direct-to-Consumer (DTC) and HCP campaigns, with the mission to improve the dialogue between patients and
physicians throughout the treatment journey.
Innovating Life Sciences Marketing with AI to Predict Care Windows
DAAP predicts potential life science brand eligibility within the U.S. population and uses that prediction to precisely time point-of-care messaging to treating HCPs during that time. Dynamic
precision targeting has demonstrated meaningfully higher script lift than traditional forms of targeting and is now applied to refresh MNT consumer audiences as the AI learns the patterns that
predict brand eligibility.
By pairing these AI-predicted brand eligibility signals with MNT, the Company can help life science brands identify the most impactful times to engage healthcare consumers. Leveraging real-world
data (RWD) through advanced machine learning models, DAAP deploys personalized, highly relevant brand communications from a proprietary point-of-care network and digital media channels to advanced
TV, programmatic display, video, social, and streaming radio.
“OptimizeRx solves the long-standing issue of siloed and disconnected marketing efforts. With DAAP, we can simultaneously deliver with AI-driven predictive targeting a variety of media to
brand-eligible patients and their treating providers,” said the Company’s President, Steve Silvestro. “We provide our clients with better value because we use our technology and life sciences
domain expertise to offer solutions with measurable commercial impact. Over 300 leading pharmaceutical brands trust us because we achieve superior audience quality that’s privacy-safe, provides
data-rich insights faster than traditional methods, and more cost-effective marketing overall. Our customers are asking for greater alignment between their physician and patient audiences because
they know they’ll achieve better outcomes, and we’re helping them get there.”
